Evaxion announces business update and third quarter 2023 financial results

Copenhagen, denmark, dec. 19, 2023 (globe newswire) -- evaxion biotech a/s (nasdaq: evax) (“evaxion” or the “company”), a clinical-stage techbio company specializing in developing ai-immunology™ powered vaccines, today provided a business update and announced its third quarter 2023 financial results.
EVAX Ratings Summary
EVAX Quant Ranking